Related Experiment Video
Updated: Aug 6, 2026
07:51
Differentiating Chondrocytes from Peripheral Blood-derived Human Induced Pluripotent Stem Cells
Published on: July 18, 2017
Red blood cell differentiation using canine-induced pluripotent stem cells
Kazuto Kimura1,2, Masaya Tsukamoto1, Kohei Shishida1
1Laboratory of Cell Pathobiology, Department of Advanced Pathobiology, Graduate School of Veterinary Science, Osaka Metropolitan University, Izumisano, 598-8531, Japan.
Stem Cells Translational Medicine
|July 19, 2026
Summary
Researchers developed a method to create red blood cells (RBCs) from canine pluripotent stem cells (PSCs). This breakthrough offers a potential solution for RBC shortages and transfusion challenges, using dogs as a translational model.
Area of Science:
- Stem cell biology
- Hematology
- Translational medicine
Background:
- Red blood cell (RBC) transfusions are critical but face supply challenges due to limited donors and compatibility issues.
- Pluripotent stem cells (PSCs) present a potential alternative for RBC production, independent of donors.
- Dogs serve as a valuable translational model for human physiology and genetics in RBC research.
Purpose of the Study:
- To establish a protocol for differentiating canine induced pluripotent stem cells (ciPSCs) into red blood cells.
- To characterize the generated RBCs for key hematopoietic and erythroid markers.
- To develop and utilize reporter cell lines for real-time monitoring of RBC differentiation.
Main Methods:
- Differentiated ciPSCs towards hematopoietic and erythroid lineages.
- Evaluated cells for marker expression, hemoglobinization, colony formation, and enucleation.
- Generated Glycophorin A (GYPA)-enhanced green fluorescent protein (EGFP) reporter ciPSC lines using CRISPR-Cas9 for GYPA visualization.
Main Results:
- Successfully generated hemoglobinized RBCs from ciPSCs, including erythroblast-like stages.
- Confirmed immature characteristics of ciPSC-derived RBCs, including limited colony formation and low enucleation.
- Demonstrated GYPA as a viable surface marker for ciPSC-derived RBCs using GYPA-EGFP reporter lines.
Conclusions:
- This study represents a foundational step in creating a canine PSC-based erythroid differentiation system.
- The developed protocol and reporter lines pave the way for future improvements in PSC-derived RBC production.
- This research supports the potential application of canine PSC-derived RBCs in transfusion medicine and research.
Related Concept Videos
01:17Stem Cell Culture
Stem cell research aims to find ways to use stem cells to regenerate and repair cellular damage. Over time, most adult cells undergo the wear and tear of aging and lose their ability to divide and repair themselves. Stem cells do not display a particular morphology or function. Adult stem cells, which exist as a small subset of cells in most tissues, keep dividing and can differentiate into a number of specialized cells generally formed by that tissue. These cells enable the body to renew and...
01:22iPS Cell Differentiation
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
01:13Induced Pluripotent Stem Cells
Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore called induced pluripotent stem...
01:13Induced Pluripotent Stem Cells
Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore called induced pluripotent stem...
01:06Induced Pluripotent Stem Cells
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic cells are...
Somatic cells are...
01:21EPS and iPS Cells in Disease Research
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...